0001104659-24-010826.txt : 20240205 0001104659-24-010826.hdr.sgml : 20240205 20240205212302 ACCESSION NUMBER: 0001104659-24-010826 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240202 FILED AS OF DATE: 20240205 DATE AS OF CHANGE: 20240205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pichl Daniel CENTRAL INDEX KEY: 0001819465 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39044 FILM NUMBER: 24597840 MAIL ADDRESS: STREET 1: C/O SPRINGWORKS THERAPEUTICS, INC. STREET 2: 100 WASHINGTON BLVD. CITY: STAMFORD STATE: CT ZIP: 06902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc. CENTRAL INDEX KEY: 0001773427 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-883-9490 MAIL ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 4 1 tm245274-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-02-02 0 0001773427 SpringWorks Therapeutics, Inc. SWTX 0001819465 Pichl Daniel C/O SPRINGWORKS THERAPEUTICS, INC. 100 WASHINGTON BLVD. STAMFORD CT 06902 0 1 0 0 Chief People Officer 1 Common Stock 2024-02-02 4 M 0 16250 27.64 A 71393 D Common Stock 2024-02-02 4 S 0 9266 43.8098 D 62127 D Common Stock 2024-02-02 4 S 0 14175 44.3144 D 47952 D Common Stock 2024-02-02 4 S 0 1997 45.9471 D 45955 D Common Stock 2024-02-02 4 S 0 743 46.4429 D 45212 D Stock Option (Right to Buy) 27.64 2024-02-02 4 M 0 16250 0 D 2033-01-05 Common Stock 16250 48750 D The transactions reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on March 9, 2023. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.05 to $44.045. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.05 to $44.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.29 to $46.23. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.31 to $47.04. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Twenty-five percent (25%) of this option shall vest and become exercisable on January 5, 2024, with the remaining seventy-five percent (75%) to vest in thirty-six (36) equal monthly installments thereafter subject to continued service to the Issuer by the Reporting Person. /s/ Francis I. Perier, Jr. as Attorney-in Fact 2024-02-05